AMGEN TO PRESENT AT JEFFERIES GLOBAL HEALTHCARE CONFERENCE

Rhea-AI Summary

Amgen (NASDAQ:AMGN) will present at the Jefferies Global Healthcare Conference at 9:55 a.m. ET on Thursday, June 4, 2026. Senior leaders, including the CFO and executives from global development and global marketing and access, will speak.

A live webcast and replay (for at least 90 days) will be accessible via the Amgen Investors section and the Investor Relations Events Calendar.

News Market Reaction – AMGN

-2.27%

-2.27% Session close to close

In the Jun 1 session, AMGN declined 2.27%, reflecting a moderate negative market reaction.

Data tracked by StockTitan Argus on the day of publication.

Market Context

This announcement outlines Amgen’s participation in the Jefferies Global Healthcare Conference, with...

Analysis

This announcement outlines Amgen’s participation in the Jefferies Global Healthcare Conference, with management presenting via webcast and providing replay access for at least 90 days. In context, recent news has included Q1 2026 revenues of $8.6B with growing EPS and nearly $2B in U.S. manufacturing commitments. Investors reviewing this type of event often focus on any incremental commentary on capital allocation, pipeline priorities, or how management frames previously issued 2026 guidance.

Key Figures

Q1 2026 revenue: $8.6B Q1 2026 GAAP EPS: $3.34 Q1 2026 non-GAAP EPS: $5.15 +5 more

8 metrics

Q1 2026 revenue $8.6B Total revenues Q1 2026

Q1 2026 GAAP EPS $3.34 GAAP EPS Q1 2026

Q1 2026 non-GAAP EPS $5.15 Non-GAAP EPS Q1 2026

Q1 2026 free cash flow $1.5B Free cash flow Q1 2026

2026 revenue guidance low $37.1B Full-year 2026 revenue guidance low end

2026 revenue guidance high $38.5B Full-year 2026 revenue guidance high end

New U.S. manufacturing spend $300M Additional U.S. manufacturing investment announced May 4, 2026

Total U.S. investments Nearly $2B U.S. manufacturing investments over last year

Historical Context

5 past events · Latest: May 27 (Positive)

Pattern 5 events

Date	Event	Sentiment	24h Move	Catalyst
May 27	Venture investment news	Positive	+0.0%	Amgen Ventures joined new funding, lifting Ember LifeSciences’ Series A to $27M.
May 19	CFO transition	Neutral	-0.3%	Announced retirement of CFO Peter Griffith and planned handover to Thomas Dittrich.
May 07	Conference presentation	Neutral	+0.8%	Scheduled presentation at Bank of America Merrill Lynch Global Healthcare Conference.
May 04	Manufacturing expansion	Positive	-1.8%	Announced additional $300M Juncos investment, bringing U.S. manufacturing to nearly $2B.
Apr 30	Earnings results	Positive	-4.8%	Reported Q1 2026 revenue growth and EPS increases with full-year 2026 guidance.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

Pattern Detected

Conference and venture-related updates have typically seen modest or minimal price reactions, while positive fundamental news like manufacturing investments and earnings sometimes coincided with short-term negative moves.

Recent Company History

Recent AMGN news has mixed operational and financial themes. On Apr 30, Q1 2026 results showed revenues of $8.6B, GAAP EPS $3.34, non-GAAP EPS $5.15, and free cash flow of $1.5B, yet shares fell about 4.75%. A further $300M U.S. manufacturing investment on May 4 brought total U.S. commitments to nearly $2B, with a -1.81% reaction. By contrast, neutral items like conference presentations and a venture investment in Ember LifeSciences saw very small moves.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

THOUSAND OAKS, Calif., May 29, 2026 /PRNewswire/ -- Amgen (NASDAQ:AMGN) will present at Jefferies Global Healthcare Conference at 9:55 a.m. ET on Thursday, June 4, 2026. Peter Griffith, executive vice president and chief financial officer at Amgen, Narimon Honarpour, senior vice president of global development at Amgen, and Kave Niksefat, senior vice president of Global Marketing and Access at Amgen, will present at the conference. The webcast will be broadcast over the internet simultaneously and will be available to members of the news media, investors and the general public.

The webcast, as with other selected presentations regarding developments in Amgen's business given by management at certain investor and medical conferences, can be found on Amgen's website, www.amgen.com, under Investors. Information regarding presentation times, webcast availability and webcast links are noted on Amgen's Investor Relations Events Calendar. The webcast will be archived and available for replay for at least 90 days after the event.

About Amgen
Amgen discovers, develops, manufactures and delivers innovative medicines to fight some of the world's toughest diseases. Harnessing the best of biology and technology, Amgen reaches millions of patients with its medicines.

More than 45 years ago, Amgen helped establish the biotechnology industry at its U.S. headquarters in Thousand Oaks, California, and it remains at the cutting edge of innovation, using technology and human genetic data to push beyond what is known today. Amgen is advancing a broad and deep pipeline and portfolio of medicines to treat cancer, inflammatory conditions, rare diseases, heart disease and obesity and obesity-related conditions.

Amgen has been consistently recognized for innovation and workplace culture, including honors from Fast Company and Forbes. Amgen is one of the 30 companies that comprise the Dow Jones Industrial Average^®, and it is also part of the Nasdaq-100 Index^®, which includes the largest and most innovative non-financial companies listed on the Nasdaq Stock Market based on market capitalization.

For more information, visit Amgen.com and follow Amgen on X, LinkedIn, Instagram, YouTube, Facebook, TikTok and Threads.

CONTACT: Amgen, Thousand Oaks
Elissa Snook, 609-251-1407 (media) 
Casey Capparelli, 805-447-1746 (investors)

 

View original content to download multimedia:https://www.prnewswire.com/news-releases/amgen-to-present-at-jefferies-global-healthcare-conference-302785887.html

SOURCE Amgen

FAQ

When will Amgen (NASDAQ:AMGN) present at the Jefferies Global Healthcare Conference in 2026?

Amgen is scheduled to present at 9:55 a.m. ET on Thursday, June 4, 2026. According to Amgen, this appearance is part of the Jefferies Global Healthcare Conference investor program.

Which Amgen executives will speak at the June 4, 2026 Jefferies Global Healthcare Conference?

Amgen states that Peter Griffith, Narimon Honarpour, and Kave Niksefat will present at the conference. They represent the company’s finance, global development, and global marketing and access leadership.

How can investors access the Amgen (AMGN) webcast from the Jefferies Global Healthcare Conference?

Investors can access the live webcast through Amgen’s website under the Investors section. According to Amgen, webcast details and links are listed on the Investor Relations Events Calendar.

Will the Amgen Jefferies Global Healthcare Conference 2026 webcast be available for replay?

Yes, Amgen plans to archive the webcast and keep it available for replay for at least 90 days. According to Amgen, replay access will be provided via the company’s Investors web pages.

Where on Amgen’s website can I find information about the Jefferies Global Healthcare Conference webcast?

Information is available on Amgen’s main website in the Investors area, specifically the Investor Relations Events Calendar. According to Amgen, this page lists presentation times, webcast access, and related links.